| Literature DB >> 28347563 |
N Kannan1, S Balaji2, N V Anil Kumar3.
Abstract
BACKGROUND: The traditional Indian medicine 'Siddha' uses metals, metalloids and minerals including toxic ones with no proven toxicity. Thalagak karuppu (TK) is remarkably stable over a century and used for treating Suram (Fever), Kaasam (Cough), Elai (Tuberculosis) and Eraippu Erumal (Bronchial Asthma).Entities:
Keywords: Arsenic; Orpiment; Realgar; Siddha; Thalagak karuppu
Year: 2017 PMID: 28347563 PMCID: PMC5607304 DOI: 10.1016/j.jaim.2016.11.005
Source DB: PubMed Journal: J Ayurveda Integr Med ISSN: 0975-9476
Fig. 1The observed (a) and predicted (b) UV–visible spectra of TK formulation.
Fig. 2Infrared transmission spectra of TK formulation.
Fig. 3The XRD pattern of TK formulation.
The validation of experimental data with JCPDS database.
| 2-theta (deg) | Predicted value | Int-f | Face | Compound | Size (nm) | System | JCPDS PDF number |
|---|---|---|---|---|---|---|---|
| 13.49 | 14.75 | 100 | (012) | As | 35.34 | Rhombhohedral | 01-1019 |
| 18.12 | 18.12 | 100 | (020) | As2S3 | 45.30 | Monoclinic | 19-0084 |
| 21.94 | 21.73, 21.85 | 20, 90 | (110) | As | 5.035 | Rhombhohedral | 01-1019, 02-0872 |
| 26.04 | 26.44 | 90 | (232) | As2O3 | 38.10 | Monoclinic | 02-0530 |
| 26.27 | 26.27 | 8 | (202) | As | 53.17 | Rhombhohedral | 01-1019 |
| 27.54 | 27.70 | 30 | (211) | As2S3 | 31.91 | Monoclinic | 19-0084 |
| 28.75 | 28.67 | 60 | (101) | As | 30.67 | Rhombhohedral | 03–0749 |
| 31.00 | 30.94 | 20 | (400) | As2S3 | 30.35 | Monoclinic | 19-0084 |
| 31.91 | 31.64 | 30 | (202) | As | 22.43 | Rhombhohedral | 02-0872 |
| 32.69 | 32.05, 32.27 | 100,100 | (012), (004) | As | 34.75 | Rhombhohedral | 03-0749, 05-0632 |
| 42.06 | 42.22 | 10 | (311) | As2S3 | 25.71 | Monoclinic | 19-0084 |
| 43.33 | 43.15 | 30 | (217) | As | 13.64 | Rhombhohedral | 02-0872 |
| 44.34 | 44.13 | 60 | (104) | As | 53.83 | Rhombhohedral | 03-0749 |
| 46.01 | 46.09 | 5 | (212) | As2S3 | 30.73 | Monoclinic | 19-0084 |
| 52.03 | 52.29 | 50 | (223) | As | 13.28 | Rhombhohedral | 03-0754 |
| 54.62 | 54.31 | 30 | (441) | As2S3 | 23.98 | Monoclinic | 19-0084 |
| 57.35 | 57.95 | 50 | (116) | As | 32.85 | Rhombhohedral | 03-0754 |
Fig. 4The SEM monograph (a) and the histogram of particle size distribution (b) of TK formulation.
Fig. 5The EDX spectra of TK formulation.
Fig. 6Zeta potential (a) and size distribution (b) of TK formulation.